Yumi Tohyama[Author] - Search Results

Year	Number of Results
2002	1
2003	2
2004	2
2005	2
2006	4
2007	1
2008	1
2009	2
2010	2
2011	1
2012	4
2013	5
2014	2
2015	3
2016	1
2017	1
2018	2
2020	1
2023	1
2024	0

1

Complement dependent TNFα production in neutrophil-like HL60 cells.

Tabata H, Morita H, Kouyama K, Tohyama Y. Tabata H, et al. Among authors: tohyama y. Biochem Biophys Rep. 2023 Apr 14;34:101465. doi: 10.1016/j.bbrep.2023.101465. eCollection 2023 Jul. Biochem Biophys Rep. 2023. PMID: 37125077 Free PMC article.

2

Complement-mediated phagocytosis--the role of Syk.

Tohyama Y, Yamamura H. Tohyama Y, et al. IUBMB Life. 2006 May-Jun;58(5-6):304-8. doi: 10.1080/15216540600746377. IUBMB Life. 2006. PMID: 16754322 Free article. Review.

3

Spinal muscular atrophy: from gene discovery to clinical trials.

Nurputra DK, Lai PS, Harahap NI, Morikawa S, Yamamoto T, Nishimura N, Kubo Y, Takeuchi A, Saito T, Takeshima Y, Tohyama Y, Tay SK, Low PS, Saito K, Nishio H. Nurputra DK, et al. Among authors: tohyama y. Ann Hum Genet. 2013 Sep;77(5):435-63. doi: 10.1111/ahg.12031. Epub 2013 Jul 23. Ann Hum Genet. 2013. PMID: 23879295 Review.

4

B cell responses to oxidative stress.

Tohyama Y, Takano T, Yamamura H. Tohyama Y, et al. Curr Pharm Des. 2004;10(8):835-9. doi: 10.2174/1381612043452947. Curr Pharm Des. 2004. PMID: 15032688 Review.

5

Protein tyrosine kinase, syk: a key player in phagocytic cells.

Tohyama Y, Yamamura H. Tohyama Y, et al. J Biochem. 2009 Mar;145(3):267-73. doi: 10.1093/jb/mvp001. Epub 2009 Jan 4. J Biochem. 2009. PMID: 19124456 Review.

6

Approach to new therapeutics: investigation by the use of MDS-derived cell lines.

Tsujioka T, Matsuoka A, Tohyama Y, Tohyama K. Tsujioka T, et al. Among authors: tohyama y. Curr Pharm Des. 2012;18(22):3204-14. doi: 10.2174/1381612811209023204. Curr Pharm Des. 2012. PMID: 22571700 Review.

7

Syk facilitates phagosome-lysosome fusion by regulating actin-remodeling in complement-mediated phagocytosis.

Tabata H, Morita H, Kaji H, Tohyama K, Tohyama Y. Tabata H, et al. Among authors: tohyama y. Sci Rep. 2020 Dec 16;10(1):22086. doi: 10.1038/s41598-020-79156-7. Sci Rep. 2020. PMID: 33328565 Free PMC article.

8

An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS.

Kida JI, Tsujioka T, Suemori SI, Okamoto S, Sakakibara K, Takahata T, Yamauchi T, Kitanaka A, Tohyama Y, Tohyama K. Kida JI, et al. Among authors: tohyama y. Leukemia. 2018 Aug;32(8):1846-1850. doi: 10.1038/s41375-018-0189-7. Epub 2018 Jun 28. Leukemia. 2018. PMID: 29955132 No abstract available.

9

KIF20A, highly expressed in immature hematopoietic cells, supports the growth of HL60 cell line.

Morita H, Matsuoka A, Kida JI, Tabata H, Tohyama K, Tohyama Y. Morita H, et al. Among authors: tohyama y. Int J Hematol. 2018 Dec;108(6):607-614. doi: 10.1007/s12185-018-2527-y. Epub 2018 Sep 4. Int J Hematol. 2018. PMID: 30182171

10

Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived cell lines.

Tsujioka T, Yokoi A, Uesugi M, Kishimoto M, Tochigi A, Suemori S, Tohyama Y, Tohyama K. Tsujioka T, et al. Among authors: tohyama y. Exp Hematol. 2013 Feb;41(2):189-97. doi: 10.1016/j.exphem.2012.10.006. Epub 2012 Oct 17. Exp Hematol. 2013. PMID: 23085465 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

34 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year